Akero Therapeutics, Inc. (AKRO) vs BridgeBio Pharma, Inc. (BBIO)
Detailed comparison between Akero Therapeutics, Inc., BridgeBio Pharma, Inc..Total Return (%)
Akero Therapeutics, Inc. (AKRO)BridgeBio Pharma, Inc. (BBIO)
Which stock do you think will perform better?
Akero Therapeutics, Inc.
AKRO
BridgeBio Pharma, Inc.
BBIO
| Metric | Akero Therapeutics, Inc. (AKRO) | BridgeBio Pharma, Inc. (BBIO) |
|---|---|---|
| Current Price | $41.53 | $35.68 |
| Change | 1.68 (4.22%) | 1.51 (4.42%) |
| Market Cap | $3.31B | $6.77B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -9.77 | -11.66 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $58.40 | $39.54 |
| 52-Week Low | $17.86 | $21.62 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-3.75 | $-3.56 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| AKRO | 10.45% | 89.89% | 104.58% | 84.50% | 126.69% | 126.69% |
| BBIO | 2.38% | 0.21% | 23.25% | 16.60% | 29.51% | 29.51% |